跳至主要内容
临床试验/NCT01713907
NCT01713907终止不适用

Evaluation of the Ulthera® System for Obtaining Lift and Tightening of the Facial Tissue and Improvement in Jawline Definition and Submental Skin Laxity

Ulthera, Inc2 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2011年6月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
发起方
Ulthera, Inc
入组人数
15
试验地点
2
主要终点
Improvement in facial wrinkles and lifting and tightening of skin

研究概览

简要总结

Up to 15 subjects will be enrolled. Enrolled subjects will receive one Ulthera® treatment on the face and neck. Follow-up visits will occur at 45, 90 and 180 days post-treatment. Study images will be obtained pre-treatment, immediately post-treatment, and at each follow-up visit.

详细描述

This is a prospective, single-center, pilot clinical trial to evaluate the efficacy of the Ulthera® System to improve jawline definition and submental skin laxity. Changes from baseline in the Fitzpatrick Facial Wrinkle Scale and facial pigmentation will be assessed at study follow-up visits. Global Aesthetic Improvement Scale scores, patient satisfaction questionnaires, and quality of life questionnaires will be obtained.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
30 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female, aged 30 to 65 years.
  • Subject in good health.
  • Score of 1 to 6 on the Fitzpatrick's Classification of Wrinkling Scale.
  • Mild to moderate rhytids in the periorbital or perioral region.
  • Mild to moderate laxity in the areas to be treated, which includes length and depth of lines.
  • Mild to moderate vertical perioral lines
  • Mild to moderate marionette lines.
  • Subjects who desire lift and tightening of periorbital, perioral, and cheek tissue, improvement in jawline definition and/or submental skin laxity
  • Understands and accepts the obligation not to undergo any other procedures in the areas to be treated through the follow-up period.
  • Willingness and ability to comply with protocol requirements, including returning for follow-up visits and abstaining from exclusionary procedures for the duration of the study.

排除标准

  • Presence of an active systemic or local skin disease that may affect wound healing.
  • Severe solar elastosis.
  • Excessive subcutaneous fat on the cheek.
  • Excessive skin laxity on the lower face and neck.
  • Deep wrinkles, numerous lines, with or without redundant skin in the areas to be treated.
  • Excessive hooding with or without redundant skin in the areas to be treated.

研究组 & 干预措施

Ulthera® treatment

Experimental

All enrolled subjects will receive one full face and neck Ulthera® treatment.

干预措施: Ulthera® Treatment (Device)

结局指标

主要结局

Improvement in facial wrinkles and lifting and tightening of skin

时间窗: 90 days post-treatment

Outcome measure determined based on a masked, qualitative assessment of standardized photographs at 90 days post-treatment compared to baseline

次要结局

  • Overall patient satisfaction(90 and 180 day post-treatment)
  • Overall aesthetic improvement(Participants will be followed up to 180 days post-treatment)

研究者

发起方
Ulthera, Inc
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验